SmartMetric (SMME) 10-K/A 19 Oct 23 2023 FY Annual report (amended) Financial data

Cover

Cover	12 Months Ended
	Jun. 30, 2023 USD ($) shares
Cover [Abstract]
Document Type	10-K/A
Amendment Flag	true
Amendment Description	SmartMetric, Inc. (the “Company”) is filing this Amendment (the “Amended Report”) to its Annual Report on Form 10-K (the “Original Report”) for the fiscal year ended June 30, 2023, which was originally filed with the Securities and Exchange Commission (“SEC”) on October 13, 2023, and subsequently amended on October 17, 2023, when the Company filed the Amendment (the “Amended Report”) to the Original Report. This Amended Report is being filed for the purpose of updating the formatting within the document due to a clerical error. The Company filed a second Amended Report on October 19, 2023 due to a clerical error.
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2023
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--06-30
Entity File Number	000-54853
Entity Registrant Name	SMARTMETRIC, INC.
Entity Central Index Key	0001301991
Entity Tax Identification Number	05-0543557
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	3960 Howard Hughes Parkway
Entity Address, Address Line Two	Suite 500
Entity Address, City or Town	Las Vegas
Entity Address, State or Province	NV
Entity Address, Postal Zip Code	89109
City Area Code	702
Local Phone Number	990-3687
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float | $	$ 2,159,324
Entity Common Stock, Shares Outstanding | shares	2,222,951,485
Document Financial Statement Error Correction [Flag]	false
Auditor Name	Victor Mokuolu, CPA PLLC
Auditor Firm ID	6771
Auditor Location	Houston, Texas

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Current assets:
Cash	$ 20,012	$ 126,791
Prepaid expenses and other current assets	8,667	13,720
Total current assets	28,679	140,511
Non-current assets
Patent costs (net of amortization)	33,750
Total assets	62,428	140,511
Current liabilities:
Accounts payable and accrued expenses	1,233,488	1,052,553
Liability for stock to be issued	3,080	115,790
Deferred Officer’s salary	769,309	753,475
Related party interest payable	305,949	253,898
Dividends payable	1,858	1,858
Due to shareholders	52,927	52,927
Covid19 SBA loan		20,832
Convertible note payable, net of discount	400,660	0
Derivative liability		120,996
Convertible interest payable	22,200	7,249
Interest payable		2,625
Shareholder loan	13,814
Total current liabilities	2,803,284	2,382,203
Total Liabilities	2,803,284	2,382,203
Series C mandatory redeemable convertible preferred stock, net of discount, authorized 1,000,000 shares, 17,300 and 65,425 shares issued and outstanding, respectively	15,728	59,478
Stockholders’ deficit:
Common stock, $.001 par value; 2,400,000,000 shares authorized, 2,222,951,485 and 647,886,336 shares issued and outstanding, respectively	2,222,952	647,886
Additional paid-in capital	26,451,292	27,546,376
Accumulated deficit	(31,431,438)	(30,496,042)
Total stockholders’ deficit	(2,756,583)	(2,301,170)
Total liabilities and stockholders’ deficit	62,428	140,511
Preferred Class B [Member]
Stockholders’ deficit:
Preferred Stock, Value, Issued	610	610
Preferred Class A [Member]
Stockholders’ deficit:
Preferred Stock, Value, Issued

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2023	Jun. 30, 2022
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	2,400,000,000	2,400,000,000
Common stock, issued	2,222,951,485	647,886,336
Common stock, outstanding	2,222,951,485	647,886,336
Series C Mandatory Redeemable Convertible Preferred Stock [Member]
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	17,300	65,425
Preferred stock, outstanding	17,300	65,425
Preferred Class B [Member]
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	610,000	610,000
Preferred stock, outstanding	610,000	610,000
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred Class A [Member]
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares issued	0	0
Preferred stock, outstanding	0	0
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Revenues
Expenses:
Officer’s salary	190,000	190,000
Advertising costs	207,935	172,047
Legal and professional fees	139,936	346,603
General and administrative expenses	145,999	280,542
Amortization expense	1,166	0
Research and development	125,867	128,616
Total operating expenses	810,903	1,117,808
Loss from operations	(810,903)	(1,117,808)
Other Income (Expenses)
Interest & Financing Expense	(127,800)	(71,254)
Gain on PPP loan forgiveness	0	20,832
Gain (loss) on conversions of debt to equity		(468,447)
Other income (expenses)	3,307
Net loss	(935,396)	(1,636,677)
Preferred stock dividends
Net loss available for common stockholders	$ (935,396)	$ (1,636,677)
Net loss per share, basic	$ 0	$ 0
Net loss per share, diluted	$ 0	$ 0
Weighted average number of common shares outstanding, basic	710,803,569	549,174,463
Weighted average number of common shares outstanding, diluted	710,803,569	549,174,463

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Deficit - USD ($)	Common Stock [Member]	Preferred Stock B [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Jun. 30, 2021	$ 446,386	$ 610	$ 25,955,367	$ (28,859,365)	$ (2,457,002)
Beginning balance, shares at Jun. 30, 2021	446,385,628	610,000
Shares issued of common stock and warrants for cash	$ 80,041		850,661		930,702
Shares issued of common stock and warrants for cash, shares	80,040,996
Shares converted from Preferred C shares to common	$ 76,955		299,546		376,501
Shares converted from Preferred C shares to common, shares	76,954,447
Common shares issued for services	$ 19,504		90,802		110,306
Common shares issued for services, shares	19,505,265
Common shares issued for finders fee	$ 25,000		350,000		375,000
Common shares issued for finders fee, shares	25,000,000
Net loss for period				(1,636,677)	(1,636,677)
Ending balance, value at Jun. 30, 2022	$ 647,886	$ 610	27,546,376	(30,496,043)	(2,301,170)
Ending balance, shares at Jun. 30, 2022	647,886,336	610,000
Shares issued of common stock and warrants for cash	$ 271,525		(8,295)		263,230
Shares issued of common stock and warrants for cash, shares	271,525,383
Shares issued against warrants	$ 244,804		(244,804)
Shares issued against warrants, shares	244,803,545
Shares converted from Preferred C shares to common	$ 14,335		29,415		43,750
Shares converted from Preferred C shares to common, shares	14,335,488
Shares issued against Liability	$ 153,993		(1,217,945)		(1,063,951)
Shares issued against Liability, shares	153,992,825
Common shares issued for services	$ 22,750		4,500		27,250
Common shares issued for services, shares	22,750,000
Common shares issued for equity funding conversions	$ 867,658		342,045		1,209,704
Common shares issued for equity funding conversions, shares	867,657,908
Net loss for period				(935,396)	(935,396)
Ending balance, value at Jun. 30, 2023	$ 2,222,951	$ 610	$ 26,451,292	$ (31,431,439)	$ (2,756,583)
Ending balance, shares at Jun. 30, 2023	2,222,951,485	610,000

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (935,396)	$ (1,636,678)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization	1,166	0
Non cash activities
Common stock issued and issuable for services	27,250	485,306
Gain (loss) on fair value of derivative liability		75,472
Amortization of debt discount		30,000
Gain on PPP forgiveness	(20,832)
Changes in assets and liabilities
Increase (Decrease) in prepaid expenses and other current assets	5,053	(8,720)
Increase in accounts payable and accrued expenses	180,935	(21,233)
(Decrease) in deferred officer salary	15,833	15,833
Increase in Due to shareholder	13,814
Increase in Convertible interest payable	14,951	1,750
Increase in interest payable	(2,625)	3,448
Decrease in Note Payable	400,660
Increase in related party interest payable	52,051	52,052
Net cash used in operating activities	(247,140)	(1,002,770)
CASH FLOWS FROM INVESTING ACTIVITIES
Patent Cost	(34,916)
Net cash used in investing activities	(34,916)
CASH FLOWS FROM FINANCING ACTIVITIES
Loans from related parties		11,584
Proceeds from sale of common stock	263,230	966,784
Proceeds from conversion of debt to equity	102,003
Proceeds from sale of Series C Preferred stock		195,000
Conversion of Series C Preferred stock	43,750
Change in dividends payable		(584)
Change in derivative Liability	(120,996)
Repayment of AJB Note		(32,717)
Net cash provided by financing activities	287,987	1,140,067
NET INCREASE (DECREASE) IN CASH	5,931	137,297
CASH BEGINNING OF PERIOD	126,791	10,325
END OF PERIOD	20,012	$ 126,791
Non cash change in stock liability	(112,710)
Non-cash activities	$ (112,710)

ORGANIZATION AND BASIS OF PRESE

ORGANIZATION AND BASIS OF PRESENTATION	12 Months Ended
	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	NOTE 1 - ORGANIZATION AND BASIS OF PRESENTATION SmartMetric, Inc. (the “Company” or “SmartMetric”) was incorporated in the State of Nevada on December 18, 2002. SmartMetric’s main product is a fingerprint sensor-activated card with a finger sensor onboard the card and a built-in rechargeable battery for portable biometric identification. This card may be referred to as a biometric card or the SmartMetric Biometric Datacard. SmartMetric has completed development of its card along with pre-mass manufacturing cards but has not yet begun to mass manufacture the biometric fingerprint activated cards. Basis of Presentation The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. The Company has adopted June 30 as its fiscal year end. Going Concern As shown in the accompanying consolidated financial statements the Company has sustained recurring losses available to common shareholders of $ 935,396 1,636,677 31,431,438 30,496,042 These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date of this filing. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Recent Accounting Pronouncements The Company has reviewed all new accounting pronouncements and has concluded that there will be no new pronouncements to adopt. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, SmartMetric Australia Pty. Ltd. All significant intercompany accounts and transactions have been eliminated in consolidation. Fair Value of Financial Instruments The carrying amounts reflected in the balance sheets for cash, accounts payable and related party payables approximate the respective fair values due to the short maturities of these items. As required by the Fair Value Measurements and Disclosures Topic of the FASB ASC, fair value is measured based on a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. The three levels of the fair value hierarchy are described below: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2: Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity). The Company at present does not have any Level 2 or Level 3 fair value instruments. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including, but not limited to, those related to income taxes and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Cash The Company considers all highly liquid debt instruments and other short-term investments with an initial maturity of three months or less to be cash equivalents. Any amounts of cash in financial institutions which exceed FDIC insured limits exposes the Company to cash concentration risk. The Company had no Research and Development Research and development costs are charged to expense as incurred. Our research and development expenses consist primarily of expenditures for electronics design and engineering, software design and engineering, component sourcing, component engineering, manufacturing, product trials, compensation, and consulting costs. Revenue Recognition The Company has not recognized revenues to date. Therefore, the Company has not yet adopted a revenue recognition policy. Reclassifications Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations. Uncertainty in Income Taxes GAAP requires the recognition and measurement of uncertain income tax positions using a “more-likely-than-not” approach. Management evaluates Company tax positions on an annual basis and has determined that as of June 30, 2023 and 2022, no Loss Per Share of Common Stock In accordance with FASB ASC 260, “Earnings Per Share,” the basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Basic net loss per share excludes the dilutive effect of stock options or warrants and convertible notes. Diluted net earnings (loss) per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be issued upon exercise of common stock options and warrants. In periods where losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of June 30, 2023 and 2022, 16,935,342 45,997,852

PREPAID EXPENSES

PREPAID EXPENSES	12 Months Ended
	Jun. 30, 2023
Prepaid Expenses
PREPAID EXPENSES	NOTE 3 - PREPAID EXPENSES Prepaid expenses were $ 8,667 13,720

COMMITMENTS

COMMITMENTS	12 Months Ended
	Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS	NOTE 4 - COMMITMENTS Lease Agreement The Company’s main office is in Las Vegas, Nevada. Rent expense under all leases for the years ended June 30, 2023 and 2022 was $ 7,387 7,613 Related Party Transactions The Company’s Chief Executive Officer has made cash advances to the Company with an aggregate amount due of $ 13,814 0 7% As of June 30, 2023 and June 30, 2022, the Company has accrued the amounts of $ 769,309 753,475 As a result of these shareholder loans and deferred officer salary, the Company has accrued a balance of $ 305,949 253,898 On September 11, 2017, we received a license to certain patents from Chaya Hendrick, our founder and CEO, related to our technologies until the expiration of the patents. As consideration, we issued Chaya Hendrick, or her assigns, 200,000 shares of Series B Convertible Preferred Stock, we agreed to pay a royalty equal to 5% of gross revenues derived from products sold related to the patents, and we agreed to make certain minimum required payments beginning at $50,000 and doubling each year thereafter. The Series B Preferred Shares may be converted at the election of holder on a basis for 50 common shares for each preferred share at any time or an aggregate of 10,000,000 common shares in exchange for all 200,000 preferred shares. 200,000 Our CEO maintains an employment agreement that stipulates a $ 190,000

DEBT

DEBT	12 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
DEBT	NOTE 5 - DEBT The Company analyzed the conversion option for derivative accounting consideration under ASC 815, “ Derivatives and Hedging,” Schedule of derivative liabilities Level 1 Level 2 Level 3 Total Derivative liability $ - $ - $ - $ -

STOCKHOLDERS_ DEFICIT

STOCKHOLDERS’ DEFICIT	12 Months Ended
	Jun. 30, 2023
Equity [Abstract]
STOCKHOLDERS’ DEFICIT	NOTE 6 - STOCKHOLDERS’ DEFICIT Preferred Stock As of June 30, 2023, the Company has 5,000,000 0.001 610,000 Each share of Series B Convertible Preferred Stock has a par value of $ 0.001 5.00 Holders of the Series B Convertible Preferred Stock are entitled to convert all or any one (1) share of the Series B Convertible Preferred Stock into fifty (50) shares of common stock. Upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary (“liquidation”), holders of the Series B Convertible Preferred Stock are entitled to receive out of the assets, whether capital or surplus, of the Company an amount equal to the Stated Value, pro rata with the holders of the common stock. The Company issued 200,000 In October 2015, the Company issued 200,000 On September 11, 2017, the Company issued an additional 210,000 As of June 30, 2023, the Company has 50,000,000 .001 no Common Stock and Warrants ● During the three months ended September 30, 2022, the Company issued 257,962,697 shares of common stock, of which 9,750,000 were issued from stock payable, 14,385,488 were converted from 48,125 shares of Preferred C shares, 22,250,000 shares were issued for advertising and promotional services and 221,327,209 shares were issued in conjunction with securities purchase agreements for net proceeds of $ 330,700 . ● During the three months ended September 30, 2022, the Company sold 0 0 4,000,000 20,000 ● During the three months ended December 31, 2022, the Company issued 582,059,999 4,000,000 578,059,999 ● During the three months ended December 31, 2022, the Company sold 0 0 ● During the three months ended March 31, 2023, the Company sold 11,000,000 60,000 ● During the three months that ended March 31, 2023, the Company issued 155,786,846 11,000,000 500,000 144,286,846 ● During the three months ended June 30, 2023, the Company sold for cash 213,333,328 116,940 ● During the three months that ended June 30, 2023, the Company issued 579,255,607 189,833,325 389,422,282 ● During the three months ended September 30, 2022, the Company issued 257,962,697 9,750,000 14,385,488 48,125 22,250,000 221,327,209 ● During the three months ended September 30, 2022, the Company sold 0 0 ● During the three months ended December 31, 2022, the Company issued 582,059,999 4,000,000 578,059,999 ● During the three months ended December 31, 2022, the Company sold 0 0 Warrants Outstanding and Exercisable at June 30, 2023: Schedule of share based compensation warrant activity Range of Exercise Prices Number of Warrants Outstanding Weighted- Average Contractual Life Remining in Years Weighted- Average Exercise Price Number Exercisable Weighted- Average Exercise Price Warrants Outstanding and Exercisable at June 30, 2022: $ 0.10 0.20 45,997,852 0.519 $ 0.18 45,997,852 $ 0.519 Warrants Outstanding and Exercisable at June 30, 2023: $ 0.10 0.20 16,935,352 0.487 $ 0.16 16,935,352 $ 0.487 Warrant Activity: As of June 30, 2023 and 2022, the following is a breakdown of the activity: June 30, 2023: Schedule of warrant activity Outstanding - beginning of year 45,997,852 Issued - Exercised - Expired (29,062,500 ) Outstanding - end of year 16,935,352 June 30, 2022: Outstanding - beginning of year 124,888,519 Issued 22,937,499 Exercised - Expired (101,828,166 ) Outstanding - end of year 45,997,852 At June 30, 2023, all of the 16,935,352 16,935,352 45,997,852 45,997,852 Equity Financing On March 5, 2020, the Company entered into an equity financing agreement with GHS Investments, LLC, a Nevada limited liability company (“Investor”). Pursuant to the agreement, the Company agrees the sell to the investor an indeterminate amount of shares of the Company’s common stock, par value $0.001 per share, up to an aggregate price of four million dollars ($4,000,000). Pursuant to the agreement, the Company is required, to within sixty (60) calendar days upon the date of execution of this agreement, use its best efforts to file with the SEC a registration statement or registration statements (as is necessary) on Form S-1, covering the resale of all of the registrable securities, which registration statement(s) shall state that, in accordance with Rule 416 promulgated under the 1933 Act, such registration statement also covers such indeterminate number of additional shares of Common Stock as may become issuable upon stock splits, stock dividends or similar transactions. Pursuant to this equity financing agreement, the Company filed the Registration S-1 on August 6, 2020. Following effectiveness of the Registration Statement, the Company shall have the discretion to deliver puts to GHS and GHS will be obligated to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) based on the investment amount specified in each put notice. The maximum amount that the Company shall be entitled to put to GHS in each put notice shall not exceed two hundred percent (200%) of the average daily trading dollar volume of the Company’s Common Stock during the ten (10) trading days preceding the put, so long as such dollar amount does not exceed $500,000. Pursuant to the Equity Financing Agreement, GHS and its affiliates will not be permitted to purchase and the Company may not put shares of the Company’s Common Stock to GHS that would result in GHS’s beneficial ownership, equaling more than 4.99% of the Company’s outstanding Common Stock. The price of each put share shall be equal to eighty percent (80%) of the Market Price (as defined in the Equity Financing Agreement). Puts may be delivered by the Company to GHS until the earlier of thirty-six (36) months after the effectiveness of the Registration Statement. The Registration Statement has not been deemed effective as of the date of this filing. Concurrently with the execution of the equity financing agreement, the company entered into a convertible promissory note, for the principal balance of $ 35,000 10% 0.0175 35,000 As of June 30, 2022, the Company was in negotiations to have this debt extinguished. As of July 2022, this debt was extinguished.

MANDATORY REDEEMABLE CONVERTIBL

MANDATORY REDEEMABLE CONVERTIBLE PREFERRED STOCK	12 Months Ended
	Jun. 30, 2023
Mandatory Redeemable Convertible Preferred Stock
MANDATORY REDEEMABLE CONVERTIBLE PREFERRED STOCK	NOTE 7 MANDATORY REDEEMABLE CONVERTIBLE PREFERRED STOCK Issuances of Series C Mandatory Redeemable Convertible Preferred Stock On January 10, 2019, the Board of Directors of the Company adopted a resolution pursuant to the Company’s Certificate of Incorporation, as amended, providing for the designations, preferences and relative, participating, optional and other rights, and the qualifications, limitations, and restrictions, of the Series C Convertible Preferred Stock. On January 14, 2019, the Company filed a Certificate of Designations for a Series C Convertible Preferred Stock. The authorized number of Series C Convertible Preferred Stock is 1,000,000 0.001 10% 105% 130% The number of Series C, mandatory redeemable convertible preferred stock shares issued and outstanding were 17,300 65,425 The Holder shall have the right at any time during the period beginning on the date which is six (6) months following the Issuance Date, to convert all or any part of the outstanding Series C Preferred Stock into fully paid and non-assessable shares of Common Stock at the Variable Conversion Price. The “Variable Conversion Price” shall mean 71% On the date which is eighteen (18) months following the Issuance Date or upon the occurrence of an Event of Default (the “Mandatory Redemption Date”), the Company shall redeem all of the shares of Series C Preferred Stock of the Holder (which have not been previously redeemed or converted). With five (5) days of the Mandatory Redemption Date, the Company shall make payment to each Holder of an amount in cash equal to the total number of shares of Series C Preferred Stock held by such Holder multiplied by the then current Stated Value. All shares of mandatorily redeemable convertible preferred stock have been presented outside of permanent equity in accordance with ASC 480, Classification and Measurement of Redeemable Securities The carrying value of the Series C mandatory redeemable convertible preferred stock at June 30, 2023 and 2022 was $ 15,728 59,478 The estimated fair value of the Series C, mandatory redeemable convertible preferred stock at June 30, 2023 and 2022 was $ 15,728 59,478 The Company recorded preferred stock dividends of $ 0 0 1,858 1,858

INCOME TAXES

INCOME TAXES	12 Months Ended
	Jun. 30, 2023
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 8 - INCOME TAXES Deferred income taxes are determined using the liability method for the temporary differences between the financial reporting basis and income tax basis of the Company’s assets and liabilities. Deferred income taxes are measured based on the tax rates expected to be in effect when the temporary differences are included in the Company’s tax return. Deferred tax assets and liabilities are recognized based on anticipated future tax consequences attributable to differences between financial statement carrying amounts of assets and liabilities and their respective tax bases. The Company recognizes interest and penalties related to income tax matters as a component of income tax expense. At June 30, 2023 and 2022, deferred tax assets consist of the following: Schedule of deferred tax assets and liabilities 2023 2022 Net operating loss carryforward $ 31,431,438 $ 10,965,212 Warrant issuances - - Deferred officer compensation 769,309 757,011 Other - 0 - 0 Valuation allowance (32,200,747 ) (11,722,223 ) Deferred tax assets, net $ - $ - At June 30, 2023, the Company had a net operating loss carry-forwards in the amount of approximately $ 31,431,438 80% Schedule of effective income tax rate reconciliation 2023 2022 Tax on income before income tax 21.00 % 21.00 % Effect of non-temporary differences (0.01 )% (0.01 )% Effect of prior year items - % - % Effect of temporary differences - % - % Change in valuation allowance (18.64 )% (19.14 )% Effective income tax rate reconciliation, percent 0.00 % 0.00 % The total amount of unrecognized tax benefits can change due to tax examination activities, lapse of applicable statutes of limitations and the recognition and measurement criteria under the guidance related to accounting for uncertainty in income taxes. The Company does not believe any significant increases or decreases will occur within the next twelve months. The Company files income tax returns in the United States (“U.S.”) federal jurisdiction. Generally, the Company is no longer subject to U.S. federal examinations by tax authorities for fiscal years prior to 2019. The Company does not file in any other jurisdiction and remains open for audit for all tax years as the statute of limitations does not begin until the returns are filed. The Company remains subject to U.S. federal examination for tax years ended 2019, 2020, 2021, 2022 and 2023.

LITIGATION

LITIGATION	12 Months Ended
	Jun. 30, 2023
Litigation
LITIGATION	NOTE 9 - LITIGATION From time to time we may be a defendant or plaintiff in various legal proceedings arising in the normal course of our business. We know of no material, active, pending or threatened proceeding against us or our subsidiaries, nor are we, or any subsidiary, involved as a plaintiff or defendant in any material proceeding or pending litigation.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Jun. 30, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 10 - SUBSEQUENT EVENTS In accordance with ASC 855-10, the Company has reviewed its operations subsequent to June 30, 2023 to the date these financial statements were issued. On July 24, 2023, the Company issued 96,800,000 96,800 On July 25, 2023, the Company issued 20,000,000 10,000 On September 5, 2023, the Company issued 61,334,886 On July 25, 2023, the Company issued 100,000 4,000

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company has reviewed all new accounting pronouncements and has concluded that there will be no new pronouncements to adopt.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, SmartMetric Australia Pty. Ltd. All significant intercompany accounts and transactions have been eliminated in consolidation.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The carrying amounts reflected in the balance sheets for cash, accounts payable and related party payables approximate the respective fair values due to the short maturities of these items. As required by the Fair Value Measurements and Disclosures Topic of the FASB ASC, fair value is measured based on a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. The three levels of the fair value hierarchy are described below: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2: Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity). The Company at present does not have any Level 2 or Level 3 fair value instruments.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including, but not limited to, those related to income taxes and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.
Cash	Cash The Company considers all highly liquid debt instruments and other short-term investments with an initial maturity of three months or less to be cash equivalents. Any amounts of cash in financial institutions which exceed FDIC insured limits exposes the Company to cash concentration risk. The Company had no
Research and Development	Research and Development Research and development costs are charged to expense as incurred. Our research and development expenses consist primarily of expenditures for electronics design and engineering, software design and engineering, component sourcing, component engineering, manufacturing, product trials, compensation, and consulting costs.
Revenue Recognition	Revenue Recognition The Company has not recognized revenues to date. Therefore, the Company has not yet adopted a revenue recognition policy.
Reclassifications	Reclassifications Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations.
Uncertainty in Income Taxes	Uncertainty in Income Taxes GAAP requires the recognition and measurement of uncertain income tax positions using a “more-likely-than-not” approach. Management evaluates Company tax positions on an annual basis and has determined that as of June 30, 2023 and 2022, no
Loss Per Share of Common Stock	Loss Per Share of Common Stock In accordance with FASB ASC 260, “Earnings Per Share,” the basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Basic net loss per share excludes the dilutive effect of stock options or warrants and convertible notes. Diluted net earnings (loss) per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be issued upon exercise of common stock options and warrants. In periods where losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of June 30, 2023 and 2022, 16,935,342 45,997,852

DEBT (Tables)

DEBT (Tables)	12 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Schedule of derivative liabilities	Schedule of derivative liabilities Level 1 Level 2 Level 3 Total Derivative liability $ - $ - $ - $ -

STOCKHOLDERS_ DEFICIT (Tables)

STOCKHOLDERS’ DEFICIT (Tables)	12 Months Ended
	Jun. 30, 2023
Equity [Abstract]
Schedule of share based compensation warrant activity	Schedule of share based compensation warrant activity Range of Exercise Prices Number of Warrants Outstanding Weighted- Average Contractual Life Remining in Years Weighted- Average Exercise Price Number Exercisable Weighted- Average Exercise Price Warrants Outstanding and Exercisable at June 30, 2022: $ 0.10 0.20 45,997,852 0.519 $ 0.18 45,997,852 $ 0.519 Warrants Outstanding and Exercisable at June 30, 2023: $ 0.10 0.20 16,935,352 0.487 $ 0.16 16,935,352 $ 0.487
Schedule of warrant activity	Schedule of warrant activity Outstanding - beginning of year 45,997,852 Issued - Exercised - Expired (29,062,500 ) Outstanding - end of year 16,935,352 June 30, 2022: Outstanding - beginning of year 124,888,519 Issued 22,937,499 Exercised - Expired (101,828,166 ) Outstanding - end of year 45,997,852

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Jun. 30, 2023
Income Tax Disclosure [Abstract]
Schedule of deferred tax assets and liabilities	Schedule of deferred tax assets and liabilities 2023 2022 Net operating loss carryforward $ 31,431,438 $ 10,965,212 Warrant issuances - - Deferred officer compensation 769,309 757,011 Other - 0 - 0 Valuation allowance (32,200,747 ) (11,722,223 ) Deferred tax assets, net $ - $ -
Schedule of effective income tax rate reconciliation	Schedule of effective income tax rate reconciliation 2023 2022 Tax on income before income tax 21.00 % 21.00 % Effect of non-temporary differences (0.01 )% (0.01 )% Effect of prior year items - % - % Effect of temporary differences - % - % Change in valuation allowance (18.64 )% (19.14 )% Effective income tax rate reconciliation, percent 0.00 % 0.00 %

ORGANIZATION AND BASIS OF PRE_2

ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Recurring losses available to common shareholders	$ 935,396	$ 1,636,677
Accumulated deficit	$ 31,431,438	$ 30,496,042

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Accounting Policies [Abstract]
Cash equivalents	$ 0	$ 0
Uncertain income tax positions	$ 0	$ 0
Dilutive shares were excluded from diluted loss per common share	16,935,342	45,997,852

PREPAID EXPENSES (Details Narra

PREPAID EXPENSES (Details Narrative) - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Prepaid Expenses
Prepaid expenses	$ 8,667	$ 13,720

COMMITMENTS (Details Narrative)

COMMITMENTS (Details Narrative) - USD ($)		12 Months Ended
	Sep. 11, 2017	Jun. 30, 2023	Jun. 30, 2022	Oct. 31, 2015
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Rent expense		$ 7,387	$ 7,613
Accrued amounts		769,309	753,475
Accrued balance of interest payable		305,949	253,898
Preferred stock, shares issued				200,000
Annual salary		$ 190,000
Series B Preferred Stock [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Preferred stock, shares issued	210,000	610,000
Number Exercisable (in Shares) | Series B Preferred Stock [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Preferred stock, shares issued		200,000
Chief Executive Officer [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Due from related party		$ 13,814	$ 0
Interest rate		7%
Related party transactions, description	200,000 shares of Series B Convertible Preferred Stock, we agreed to pay a royalty equal to 5% of gross revenues derived from products sold related to the patents, and we agreed to make certain minimum required payments beginning at $50,000 and doubling each year thereafter. The Series B Preferred Shares may be converted at the election of holder on a basis for 50 common shares for each preferred share at any time or an aggregate of 10,000,000 common shares in exchange for all 200,000 preferred shares.

DEBT (Details)

DEBT (Details)	Jun. 30, 2023 USD ($)
Platform Operator, Crypto-Asset [Line Items]
Derivative liability
Fair Value, Inputs, Level 1 [Member]
Platform Operator, Crypto-Asset [Line Items]
Derivative liability
Fair Value, Inputs, Level 2 [Member]
Platform Operator, Crypto-Asset [Line Items]
Derivative liability
Fair Value, Inputs, Level 3 [Member]
Platform Operator, Crypto-Asset [Line Items]
Derivative liability

STOCKHOLDERS' DEFICIT (Details)

STOCKHOLDERS' DEFICIT (Details) - $ / shares	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Equity [Abstract]
Exercise price range, lower range limit	$ 0.10	$ 0.10
Exercise price range, upper range limit	$ 0.20	$ 0.20
Number of warrants outstanding (in shares)	16,935,352	45,997,852
Weighted-average contractual life remaining in years	5 months 25 days	6 months 6 days
Weighted- average exercise price	$ 0.16	$ 0.18
Number exercisable (in shares)	16,935,352	45,997,852
Weighted- average exercise price	$ 0.487	$ 0.519

STOCKHOLDERS' DEFICIT (Details

STOCKHOLDERS' DEFICIT (Details 1) - shares	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Equity [Abstract]
Outstanding - beginning of year	45,997,852	124,888,519
Issued		22,937,499
Exercised
Expired	(29,062,500)	(101,828,166)
Outstanding - end of year	16,935,352	45,997,852

STOCKHOLDERS_ DEFICIT (Details

STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)		3 Months Ended				12 Months Ended
	Mar. 05, 2020	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 11, 2017	Oct. 31, 2015
Class of Stock [Line Items]
Preferred stock, shares issued									200,000
Stock issued		189,833,325	11,000,000	4,000,000		200,000
Number of shares issued		579,255,607	155,786,846	582,059,999	4,000,000
Proceeds from sale of common stock		$ 116,940	$ 60,000	$ 0	$ 0
Number of common stock sold		213,333,328	11,000,000	0	0
Value of common stock issued					$ 20,000
Warrants are vested		16,935,352				16,935,352	45,997,852
Class of warrants expire						16,935,352	45,997,852
Convertible Promissory Note [Member]
Class of Stock [Line Items]
Registration Statement, description	Company shall have the discretion to deliver puts to GHS and GHS will be obligated to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) based on the investment amount specified in each put notice. The maximum amount that the Company shall be entitled to put to GHS in each put notice shall not exceed two hundred percent (200%) of the average daily trading dollar volume of the Company’s Common Stock during the ten (10) trading days preceding the put, so long as such dollar amount does not exceed $500,000. Pursuant to the Equity Financing Agreement, GHS and its affiliates will not be permitted to purchase and the Company may not put shares of the Company’s Common Stock to GHS that would result in GHS’s beneficial ownership, equaling more than 4.99% of the Company’s outstanding Common Stock. The price of each put share shall be equal to eighty percent (80%) of the Market Price (as defined in the Equity Financing Agreement). Puts may be delivered by the Company to GHS until the earlier of thirty-six (36) months after the effectiveness of the Registration Statement. The Registration Statement has not been deemed effective as of the date of this filing.
Principal balance (in Dollars)	$ 35,000
Interest rate, percentage	10%
Fixed conversion price (in Dollars per share)	$ 0.0175
Deferred financing costs (in Dollars)	$ 35,000
Common Stock [Member]
Class of Stock [Line Items]
Shares issued for services						22,750,000	19,505,265
Common Stock [Member] | Legal Sevices [Member]
Class of Stock [Line Items]
Shares issued for services			500,000
Securities Purchase Agreement [Member]
Class of Stock [Line Items]
Number of shares issued		389,422,282	144,286,846	578,059,999
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized		5,000,000				5,000,000
Preferred stock, par value		$ 0.001				$ 0.001
Preferred stock, shares issued		610,000				610,000		210,000
Preferred stock, shares outstanding		610,000				610,000
Series B Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, par value		$ 0.001				$ 0.001
Preferred stock, stated value per share (in Dollars per share)		$ 5				$ 5
Conversion basis						Holders of the Series B Convertible Preferred Stock are entitled to convert all or any one (1) share of the Series B Convertible Preferred Stock into fifty (50) shares of common stock.
Preferred Class A [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized		50,000,000				50,000,000	50,000,000
Preferred stock, par value		$ 0.001				$ 0.001	$ 0.001
Preferred stock, shares issued		0				0	0
Preferred stock, shares outstanding		0				0	0
Common Stock [Member]
Class of Stock [Line Items]
Number of shares issued				582,059,999	257,962,697
Stock issued for stock payable				4,000,000	9,750,000
Number of stock converted					14,385,488
Shares issued for services					22,250,000
Stock Issued During Period, Shares, Other					221,327,209
Proceeds from sale of common stock					$ 330,700
Shares issued for finder's fee				578,059,999	221,327,209
Preferred Stock [Member]
Class of Stock [Line Items]
Number of stock converted					48,125

MANDATORY REDEEMABLE CONVERTI_2

MANDATORY REDEEMABLE CONVERTIBLE PREFERRED STOCK (Details Narrative) - USD ($)		12 Months Ended
	Jan. 14, 2019	Jun. 30, 2023	Jun. 30, 2022	Oct. 31, 2015
Preferred stock shares issued (in Shares)				200,000
Preferred shares convertible average market price rate		71%
Preferred stock dividends		$ 0	$ 0
Accrued dividends payable		$ 1,858	$ 1,858
Series C Convertible Preferred Stock [Member]
Preferred stock, authorized (in Shares)	1,000,000
Preferred stock, par value (in Dollars per share)	$ 0.001
Series C Mandatory Redeemable Convertible Preferred Stocks [Member]
Dividend percent	10%
Series C Mandatory Redeemable Convertible Preferred Stock [Member]
Preferred stock, authorized (in Shares)		1,000,000	1,000,000
Preferred stock shares issued (in Shares)		17,300	65,425
Preferred stock shares outstanding (in Shares)		17,300	65,425
Description of conversion of stock		The Holder shall have the right at any time during the period beginning on the date which is six (6) months following the Issuance Date, to convert all or any part of the outstanding Series C Preferred Stock into fully paid and non-assessable shares of Common Stock at the Variable Conversion Price. The “Variable Conversion Price” shall mean 71% multiplied by the Market Price (representing a discount rate of 29%). “Market Price” means the average of the two (2) lowest Trading Prices (as defined here) for the Common Stock during the fifteen (15) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date.
Fair value of convertible preferred stock (in Dollars)		$ 15,728	$ 59,478
Estimated fair value of convertible preferred stock		$ 15,728	$ 59,478
Series C Mandatory Redeemable Convertible Preferred Stock [Member] | Minimum [Member]
Dividend percent	105%
Series C Mandatory Redeemable Convertible Preferred Stock [Member] | Maximum [Member]
Dividend percent	130%

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Income Tax Disclosure [Abstract]
Net operating loss carryforward	$ 31,431,438	$ 10,965,212
Warrant issuances
Deferred officer compensation	769,309	757,011
Other	0	0
Valuation allowance	(32,200,747)	(11,722,223)
Deferred tax assets, net

INCOME TAXES (Details 1)

INCOME TAXES (Details 1)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Income Tax Disclosure [Abstract]
Tax on income before income tax	21%	21%
Effect of non-temporary differences	(0.01%)	(0.01%)
Effect of prior year items
Effect of temporary differences
Change in valuation allowance	(18.64%)	(19.14%)
Effective income tax rate reconciliation, percent	0%	0%

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative)	12 Months Ended
	Jun. 30, 2023 USD ($)
Income Tax Disclosure [Abstract]
Operating loss carryforwards, limitations on use	Company had a net operating loss carry-forwards in the amount of approximately $31,431,438 million available to offset future taxable income through 2040.
Net operating loss carry-forwards	$ 31,431,438
Taxable income, percentage	80%
Income tax examination, description	The Company remains subject to U.S. federal examination for tax years ended 2019, 2020, 2021, 2022 and 2023.

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)		1 Months Ended		3 Months Ended
	Sep. 05, 2023	Jul. 25, 2023	Jul. 24, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022
Subsequent Event [Line Items]
Stock issued during the period, shares				579,255,607	155,786,846	582,059,999	4,000,000
Stock issued during the period, value							$ 20,000
Subsequent Event [Member] | Unrelated Party [Member]
Subsequent Event [Line Items]
Stock issued for conversion of note payable, shares			96,800,000
Stock issued for conversion of note payable, value			$ 96,800
Stock issued during the period, shares		20,000,000
Stock issued during the period, value		$ 10,000
Stock issued for conversion of note payable in cashless warrant exercise, shares	61,334,886
Stock issued during the period, shares		100,000
Stock issued during the period, value		$ 4,000